Paying for Residential Treatment With an HSA or FSA: IRS Publication 502, the 7.5% Deduction Floor, and What to Ask Billing

, ,
Addiction Treatment Near Atherton

In admissions conversations, money questions usually arrive in the same order: does insurance cover this, what is left over, and how do we pay it. The third question is where families most often overlook something they already have, a health savings account (HSA) or a health flexible spending account (FSA) sitting in an employer benefits portal. Those accounts can often be used for residential addiction treatment, but the rules are specific, and the paperwork matters as much as the eligibility. This guide explains how the tax rules treat residential treatment, where families get caught, and what to ask a billing office before you pay.

What IRS Publication 502 Says About Addiction Treatment

Under IRS Publication 502, amounts paid for an inpatient’s treatment at a therapeutic center for alcohol or drug addiction count as medical expenses, and that includes meals and lodging the center provides during treatment. Because HSAs and health FSAs reimburse qualified medical expenses, residential addiction treatment can generally be paid from either account, and costs not reimbursed by any account or insurer can be claimed as an itemized deduction, but only the portion of total medical expenses that exceeds 7.5% of adjusted gross income for the year.

You can read the full list of qualifying expenses in IRS Publication 502. The same publication also generally allows transportation costs to and from medical care, which can matter for families driving to Northern California for admission or family sessions. Tax rules are updated each year, so check the current edition for the year you are filing.

HSA, FSA, or the Tax Deduction: How the Three Differ

These three tools all rely on the same definition of a medical expense, but they behave very differently in practice.

  • Health savings account (HSA): The money is yours, rolls over year to year, and can reimburse qualified expenses incurred any time after the account was opened, even if you reimburse yourself later.
  • Health flexible spending account (FSA): Funded through your employer plan for a single plan year, and under the uniform coverage rule your full annual election is generally available from the first day of the plan year, even before it has been deducted from your paychecks.
  • Itemized medical deduction: Only available if you itemize, and only for unreimbursed expenses above the 7.5% of adjusted gross income threshold.

One rule ties them together: you cannot use the same dollar twice. An expense paid from an HSA or FSA cannot also be deducted on Schedule A.

Where HSA and FSA Claims for Treatment Go Wrong

Eligibility is rarely the problem. Documentation and timing usually are. These are the issues we see most often when families try to use these accounts after a residential stay.

  • Vague billing statements: An invoice that reads only “program fee” gives an FSA administrator nothing to approve and gives you nothing to show if an HSA withdrawal is ever questioned.
  • The adult-child gap: Health FSAs can generally cover a child through the end of the year they turn 26, but HSA funds can generally be used only for a spouse or a tax dependent, so a parent paying for an independent adult child from an HSA may be making a non-qualified withdrawal.
  • Non-qualified withdrawals: If you are under 65, HSA money spent on something that does not qualify is taxed as income and generally carries an additional 20% tax.
  • Plan-year deadlines: FSA balances follow use-it-or-lose-it rules, softened only if your employer offers a grace period of up to 2.5 months or a limited carryover, and plans offer one or the other, not both.
  • Missing receipts: HSA custodians generally do not pre-approve spending, so the burden of proof sits with you if the IRS ever asks. Keep the itemized statement, proof of payment, and dates of service together.

Separately, amenity charges that are not part of treatment, such as personal purchases or optional add-ons, may not qualify. Ask billing to list them separately so the treatment charges stand on their own.

What to Do Today: Five Checks Before You Pay

These steps take less than an hour, and they prevent most of the problems above.

  1. Log in to your benefits portal today. Write down your HSA balance, your FSA annual election, your FSA plan-year end date, and whether your plan offers a grace period or carryover.
  2. Confirm whose expense it is. If the person entering treatment is an adult child, check whether they are your tax dependent before using HSA funds. If not, an FSA, their own account, or another source may be the cleaner route.
  3. Ask billing these exact questions: “Can you provide an itemized statement showing dates of service, level of care, the treating facility’s name and license, and any non-treatment charges listed separately?” and “Do you provide a superbill or a letter of medical necessity if my FSA administrator asks for one?”
  4. Verify insurance first. Account funds work best on what insurance leaves behind: deductibles, coinsurance, and out-of-network balances. Our team can check your insurance benefits before you commit account dollars.
  5. Create one folder. Keep the itemized statement, payment receipts, and any explanation of benefits from your insurer together for at least as long as your tax preparer recommends.

If you would rather walk through the numbers with someone, call us at (877) 328-1968. We can explain what our statements include so you know what your administrator will see.

A Clinical Note: Do Not Let Paperwork Delay Safe Care

From the clinical side, the most important point is that payment logistics should never set the timeline for medical safety. Withdrawal from alcohol or benzodiazepines can cause seizures and can be life-threatening, which is why medical supervision is required. Do not stop drinking or stop a benzodiazepine abruptly while waiting for an FSA claim to clear or an HSA transfer to post. If someone is already in withdrawal, treat it as a medical issue first and sort out reimbursement afterward. You can learn how withdrawal management fits into care on our residential treatment page.

The National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the National Institute on Drug Abuse (NIDA) both describe addiction as a treatable medical condition, and that framing is exactly how the tax code treats it too: as medical care, not as a lifestyle expense.

If Cost Is Still the Barrier

Account funds help, but they do not close every gap. If cost is stopping someone from getting any care at all, the SAMHSA National Helpline is free, confidential, and available 24 hours a day, and it can point families toward state-funded and sliding-scale options. For a broader look at levels of care and what each involves, see our overview of addiction treatment.

For a conversation about your situation, including how our billing statements are itemized and what to ask your benefits administrator, reach our admissions team at (877) 328-1968.

A Note From Practice

Families often tell us they found the HSA months after a loved one came home, when the receipts were already scattered. The accounts were there the whole time. Asking for an itemized statement on day one costs nothing and can save a great deal of stress later. Treat the paperwork as part of the treatment plan, the same way you would a medication list or a discharge plan.

This article is for educational purposes only and is not tax, legal, or medical advice. Tax rules change and depend on individual circumstances, so confirm how they apply to you with a qualified tax professional and your plan administrator. If you or someone you love is in immediate danger, call 911. For a mental health or substance use crisis, call or text 988.

/by

Medi-Cal and Residential Addiction Treatment in California: The County Access Line, the 16-Bed Rule, and What to Ask Before You Call

,
how to tell your employer you're going to residential addiction treatment private conversation

If Medi-Cal is your only coverage, or the only coverage of someone you love, the route into residential addiction treatment in California looks different from the one most treatment websites describe. The calls that go nowhere usually go nowhere for one reason: the family is calling the wrong door. This guide lays out how Medi-Cal actually pays for residential care, who you call first, and what to have in hand before you dial.

How Medi-Cal Pays for Residential Treatment

In California, Medi-Cal pays for residential addiction treatment through county behavioral health systems, not through the health plan named on most members’ cards. Adults ages 19 to 64 generally qualify for Medi-Cal with household income up to 138 percent of the federal poverty level, and in counties that take part in the Drug Medi-Cal Organized Delivery System (DMC-ODS), residential treatment is a covered benefit. The entry point is the county’s substance use disorder access line, which arranges an assessment based on the ASAM Criteria and then refers to a county-contracted residential program.

That paragraph is the whole map. Medi-Cal is California’s Medicaid program. It is not Medicare, which is the federal program mostly for people 65 and older, and mixing the two up on the first call costs time. Most Medi-Cal members are enrolled in a managed care health plan for doctor visits and prescriptions, but specialty substance use treatment, including residential care, is generally handled by the county where the member lives. Coverage details, the list of contracted programs, and wait times differ from county to county, and federal Medicaid rules are changing in 2026 and 2027, so confirm current eligibility with your county rather than relying on any single article, including this one.

Why Calls to Private Programs Stall

In consultation calls, a pattern we hear again and again is a family that has spent a week phoning private residential programs from a search engine, each one asking for insurance information and then going quiet. The reasons are structural, not personal:

  • Certification gap: A program has to be Drug Medi-Cal certified and contracted with a county to bill Medi-Cal, and many private residential programs are neither.
  • The 16-bed rule: Federal Medicaid has long barred payment for adults ages 21 to 64 in an “institution for mental diseases” with more than 16 beds, and California’s DMC-ODS operates under federal waiver authority that allows residential substance use care in larger facilities only through the county system.
  • County of residence: Medi-Cal is tied to the county where the member lives, so a program in a neighboring county may not be reachable without a referral or a county-to-county arrangement.
  • Payer of last resort: When someone has both private insurance and Medi-Cal, the private plan pays first, so the private plan’s rules, network, and authorization process come into play before Medi-Cal does.

None of this means Medi-Cal members cannot get residential care. It means the door is the county, and calling it first usually saves days.

What to Do Today, Before You Call

Gather four things before you pick up the phone. This takes about ten minutes and makes the call far more productive.

  1. The Medi-Cal card or benefits identification number. If the card is lost, the county social services office can confirm active coverage.
  2. The county of residence. This is the county where the person lives and receives mail, not the county where a preferred program sits.
  3. A plain list of what is being used, how much, and when the last use was. Include alcohol, prescription medications, and anything bought on the street. Admissions and assessment staff need this to judge withdrawal risk safely, so accuracy matters more than tidiness.
  4. A current medication list, including doses and the prescribing doctor’s name.

Then find the county’s substance use disorder access line. It is usually posted on the county behavioral health department’s website, and many counties list it on the back of member materials. California’s approach is meant to be “no wrong door,” so if you reach the managed care plan first, ask them directly for the county substance use access line number. If you cannot find a county number, the SAMHSA National Helpline at 1-800-662-4357 is free, confidential, and open 24 hours a day, and can point you toward local options.

Four Questions to Ask the County Access Line

Write these down and ask them in this order:

  1. “Does this county participate in the Drug Medi-Cal Organized Delivery System, and is residential treatment covered here?”
  2. “How is the assessment done, by phone or in person, and how soon can it happen?”
  3. “If the assessment recommends residential care and no bed is open, what interim services are available while we wait?”
  4. “Is withdrawal management, meaning medically supervised detox, arranged separately or as part of the residential referral?”

The fourth question matters more than it sounds. Withdrawal from alcohol or benzodiazepines can cause seizures and can be life-threatening, and stopping either one abruptly at home is not safe. Medical supervision is required. If the person drinks heavily every day or takes benzodiazepines such as alprazolam, clonazepam, or lorazepam daily, say so clearly on the first call so the county can route to a setting with medical staff. If someone is in withdrawal right now and is confused, shaking severely, hallucinating, or has had a seizure, call 911. If someone is in emotional crisis or thinking about suicide, call or text 988.

What the Assessment Covers and What Comes Next

The county assessment uses the ASAM Criteria, a framework published by the American Society of Addiction Medicine that looks at withdrawal risk, physical health, mental health, readiness for change, relapse risk, and the home environment. The goal is to match the person to the least restrictive level of care that is still safe, which may be residential, an intensive outpatient program, or outpatient services with medication. The National Institute on Drug Abuse describes this kind of individualized matching as a core principle of effective treatment, and notes that staying in treatment long enough matters.

Families often expect a yes or no on the first call. More often, the first call produces an appointment, the assessment produces a recommendation, and the recommendation produces a referral to a specific program. Some counties move through this in days; others have waits. If there is a wait, ask about outpatient services and medication for opioid or alcohol use disorder in the meantime. Those can start sooner and are not a lesser choice.

If you also have private insurance, or are weighing whether a private plan through work or Covered California would open more options, the residential treatment overview and our insurance verification page explain what a benefits check can and cannot tell you.

Where Bodhi Fits

Bodhi is a treatment consulting and referral service based in Capitola. When Medi-Cal is the only coverage, the honest answer is often that the county system is the right path, and we will tell you that rather than send you through a list of programs that cannot bill Medi-Cal. When there is other coverage, or the situation is complicated by a co-occurring mental health condition, a pending court date, or a recent hospital stay, a consultation can help sort out which route fits. You can reach us at (877) 328-1968.

The single most useful thing you can do today is find your county’s substance use access line and write down the four questions above. If you want help reading what the county tells you, or if the county route stalls, call (877) 328-1968 and we will walk through it with you.

This article is for educational purposes only and is not medical, legal, or insurance advice. Medi-Cal eligibility rules, county benefits, and federal Medicaid requirements change; confirm current details with your county behavioral health department or Medi-Cal office. Do not stop alcohol or benzodiazepines suddenly without medical supervision. If you or someone you love is in immediate danger, call 911. For mental health crisis support, call or text 988.

/by

Naloxone at Discharge From Residential Treatment: Lost Tolerance, the Four-Hour Rule, and What to Ask Before Going Home

, ,
relapse after cocaine recovery what to do

The last week of residential treatment is usually the most hopeful one. Sleep has come back, appetite has returned, and the person who arrived exhausted is now making plans. From a clinical point of view, it is also the week we spend the most time on overdose prevention, because for anyone whose history includes opioids, the days right after discharge carry a risk that did not exist when they walked in. This post explains that risk in practical terms, what naloxone does, and the specific items to settle before discharge day.

Why the First Weeks After Discharge Carry Higher Overdose Risk

Residential treatment lowers a person’s tolerance to opioids. That is the point of stopping use, but it has a dangerous side. A dose a person used regularly before admission can be far more than their body can now handle. The National Institute on Drug Abuse (NIDA) and other federal health agencies describe reduced tolerance after a period of abstinence, such as after treatment or incarceration, as a recognized overdose risk. In today’s unregulated drug supply, where fentanyl turns up in pills and powders sold as something else, a single return to use can be fatal even for someone who never knowingly used fentanyl.

The mechanisms that raise risk after discharge are well understood:

  • Lost tolerance: After days or weeks without opioids, the body no longer adapts to the doses it once handled, so a familiar amount can stop breathing.
  • Unknown supply: Fentanyl and other potent synthetics are mixed into counterfeit pills and other drugs, so a person cannot judge strength by appearance or by what they were told.
  • Using alone: A first return to use often happens in private, out of shame, which means no one is present to give naloxone or call 911.
  • Combining sedatives: Opioids taken with alcohol, benzodiazepines, or sleep medications slow breathing more than either does alone.

None of this means relapse is expected. Many people leave treatment and never return to use. It means the plan has to account for the possibility honestly, the same way a cardiac patient leaves the hospital knowing where the nearest emergency room is.

What Naloxone Does, in Plain Numbers

Naloxone is a medication that reverses an opioid overdose by blocking opioids from acting on the brain, and according to the Centers for Disease Control and Prevention (CDC) it can restore normal breathing within 2 to 3 minutes in a person whose breathing has slowed or stopped. The CDC also advises that more than one dose may be needed when fentanyl is involved, and that whoever gives naloxone should stay with the person until emergency help arrives or for at least four hours. Naloxone is sold without a prescription in all 50 states, and it does not harm someone who is overdosing on a non-opioid drug, so it is always appropriate to use if an opioid overdose is suspected.

That paragraph is the single most useful thing a family can memorize. CDC figures also show why it matters: of the 105,007 drug overdose deaths in the United States in 2023, about 76% involved an opioid, and a potential bystander was present in nearly 43% of those deaths. A bystander with naloxone is someone in a position to act.

One limitation families often do not know: a person cannot give naloxone to themselves during an overdose. The medication only works if someone nearby knows where it is and how to use it.

What We See in the Week Before Discharge

As a counselor and interventionist, I have sat through many discharge planning meetings, and a pattern repeats. The client is focused on going home, the family is focused on the client, and the naloxone conversation gets one sentence at the end. Clients sometimes push back on it directly: “If I carry it, it’s like I’m planning to use.” Parents sometimes say the same thing in a different way: “We don’t want to send the wrong message.”

Our experience is the opposite. When naloxone is handled as routine safety equipment, like a smoke detector, it lowers the emotional charge. The client does not have to bring it up later, in a moment of shame, and the family is not left wondering whether they are allowed to keep it in the house. The conversation is short and practical when it happens early, and awkward and rushed when it happens in the parking lot.

The other thing we see often: the naloxone a family bought months ago is in a glove box, expired or heat-exposed, and nobody can find it. A plan only works if the medication is current, visible, and known to everyone in the home.

Your Pre-Discharge Naloxone Checklist

Do these before discharge day. Each one takes a few minutes.

  1. Buy or confirm two doses. Check the expiration date printed on the box. Because fentanyl can require more than one dose, a two-dose pack is the practical minimum.
  2. Pick one fixed location at home and tell every adult in the household where it is. Avoid cars, where heat and cold can affect the device.
  3. Read the package instructions together, out loud, with the person coming home. It takes under five minutes.
  4. Agree on the sequence: call 911, give naloxone, follow the dispatcher’s instructions, give a second dose if there is no response after a few minutes, and stay for at least four hours.
  5. Ask the treatment team three questions at the discharge meeting: Will naloxone be provided at discharge, or should we buy it? Is the person leaving on buprenorphine, naltrexone, or another medication, and when is the first follow-up appointment? Who do we call if we are worried in the first week?

If the person is leaving on medication for opioid use disorder, confirm the first outpatient appointment date before discharge. A gap between the last dose given in treatment and the first prescription filled at home is a known weak point, and the clinical team can help close it.

Safety Notes That Apply to Everyone

Naloxone works only on opioids. It will not reverse alcohol poisoning or a benzodiazepine-only overdose, though it does no harm if given in those situations. Separately, withdrawal from alcohol or benzodiazepines can cause seizures and can be life-threatening, so anyone stopping either substance needs medical supervision rather than quitting abruptly at home. If a person returns to heavy drinking or benzodiazepine use after discharge and then wants to stop again, they should contact a medical provider or treatment program first.

Good Samaritan laws in most states, including California, offer certain legal protections to people who call 911 during an overdose. Families should never delay calling for help.

How the Discharge Plan Fits Into Ongoing Care

Overdose prevention is one part of a broader aftercare plan. For many people, stepping down from residential treatment to a structured outpatient program keeps support in place during the same weeks when risk is highest. That might include individual therapy, group sessions, medication management, and family involvement.

If you are considering treatment for yourself or someone you love and want to understand what discharge planning looks like at Bodhi Addiction Treatment in Northern California, call us at (877) 328-1968. We can walk you through admissions, what to expect in the first week, and how we prepare clients and families for going home. You can also verify your insurance online before you call.

The SAMHSA National Helpline (1-800-662-4357) offers free, confidential treatment referral 24 hours a day. If you or someone you know is in crisis or thinking about suicide, call or text 988. In an overdose or medical emergency, call 911 immediately.

Questions about naloxone, discharge, or aftercare? Our admissions team is available at (877) 328-1968.

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always follow the instructions on naloxone packaging and the guidance of a qualified health care provider. If you suspect an overdose, call 911.

/by

Counting Standard Drinks Before the Admissions Call: The 14-Gram Rule, Bottle Math, and What to Tell Admissions

, ,
drinking alone

One of the first questions an admissions coordinator asks about alcohol is simple: how much do you drink on a typical day? It is also one of the questions people most often answer inaccurately, not because they are hiding anything, but because “a few glasses” or “a bottle” means very different things depending on the glass, the bottle, and what is in it. This guide explains how to turn what you actually drink into standard drinks before you call, why that number matters to the people planning your care, and what else to have ready.

What a Standard Drink Is, in Numbers

In the United States, one standard drink contains about 14 grams, or 0.6 fluid ounces, of pure alcohol, according to the National Institute on Alcohol Abuse and Alcoholism (NIAAA). That equals a 12-ounce beer at 5% alcohol, a 5-ounce glass of wine at 12%, or a 1.5-ounce shot of 80-proof (40%) spirits. Using that definition, a standard 750 ml bottle of 12% wine holds about 5 standard drinks, and a 750 ml bottle (a “fifth”) of 80-proof vodka or whiskey holds about 17. Before a residential treatment admissions call, convert your usual drinking day into standard drinks using these figures, because the intake team uses that number, together with the time of your last drink and any past withdrawal history, to judge how closely withdrawal needs to be medically monitored.

Why the Usual Answer Undercounts

When I talk with people and families during intake, the gap between what someone reports and what they actually consume is rarely about honesty. It is about containers. NIAAA notes that a 12-ounce craft beer at 10% alcohol is two standard drinks, not one. The same logic runs through everything people commonly drink:

  • A 16-ounce pint of 7% IPA is about 1.9 standard drinks.
  • A 9-ounce home pour of 14% red wine is about 2.1 standard drinks.
  • A 24-ounce can of 12% malt beverage is about 4.8 standard drinks.
  • A 1.75-liter bottle (a “handle”) of 80-proof spirits is about 39 standard drinks.

Those figures are simple arithmetic from NIAAA’s 0.6-ounce definition: multiply the ounces in the container by its alcohol percentage, then divide by 0.6. Someone who says “three beers a night” and drinks three 16-ounce cans of 8% beer is actually having about six standard drinks. Someone who says “a bottle of wine” may be describing 5 standard drinks, or closer to 6 if the label reads 14%. Neither person is minimizing. They are counting containers, and admissions needs to count alcohol.

Why the Number Matters to Admissions

The intake team is not asking about quantity to judge you. The answer feeds several concrete decisions that are made before you arrive:

Withdrawal risk: Larger and longer daily intake generally raises the likelihood of significant withdrawal, which is why the team asks about amount and duration together.

Level of medical monitoring: The count, combined with history, helps decide whether you need medically supervised withdrawal management on arrival or can start directly in the residential program.

Timing of admission: The time of your last drink tells staff where you are likely to be in the withdrawal window when you walk in, which affects how soon you should be seen.

Medication planning: Prescribers use the drinking history to plan withdrawal medication and to check for interactions with anything else you take.

Safety of other substances: Daily alcohol combined with benzodiazepines, sleep medications, or opioids changes the risk picture, so those need to be reported alongside the alcohol count.

Safety note: Alcohol withdrawal can cause seizures and, in severe cases, delirium tremens, both of which can be life-threatening. The same is true of benzodiazepine withdrawal. If you drink heavily every day, do not stop abruptly on your own before admission. Medical supervision is required. Call us at (877) 328-1968 before you change how much you drink, and call 911 if someone is confused, hallucinating, or having a seizure.

A Five-Minute Drink Count You Can Do Today

You can do this on paper or in your phone’s notes before you call. It works for you, and it works for a family member who is helping someone prepare.

  1. Write down the last seven days. One line per day. Recent days are more useful than a “typical” day from memory.
  2. List each drink by container. For example: “two 16 oz cans” or “most of a 750 ml bottle of wine.”
  3. Find the percentage on the label. Write the ABV next to each item. If you can’t check, write “unknown” rather than guessing low.
  4. Do the math. Ounces times ABV, divided by 0.6. A 750 ml bottle is about 25.4 ounces; a handle is about 59 ounces.
  5. Total each day and note the highest. Admissions will want both your typical day and your heaviest recent day.
  6. Add the time of your last drink. Date and approximate hour.

If the numbers feel uncomfortable to write down, that is common. The count is clinical information, the same way a blood pressure reading is. It is used to plan a safer start, not to label you.

What Else to Have Ready for the Call

The drink count is the center of the conversation, but a few other details change the plan just as much. Have answers ready for these questions:

  • How long have you been drinking at roughly this level: weeks, months, or years?
  • Have you ever had withdrawal symptoms such as shaking, sweating, or not sleeping when you cut back?
  • Have you ever had a withdrawal seizure, hallucinations, or delirium tremens, or been hospitalized for withdrawal?
  • Do you take any benzodiazepines (such as alprazolam, lorazepam, or clonazepam), sleep medications, opioids, or gabapentin, prescribed or not?
  • Are you currently prescribed any medication for alcohol use disorder?
  • Do you have liver problems, diabetes, heart conditions, or a history of seizures unrelated to alcohol?

A history of withdrawal seizures or delirium tremens is one of the most important things to mention, even if it happened years ago. Past complicated withdrawal is a key factor clinicians weigh when planning medically supervised care, so leaving it out can lead to a plan that is less cautious than it should be.

How the Count Shapes a Residential Plan in Northern California

At Bodhi, the intake call is where the drink count, the timeline, and the medical history come together. That information helps determine whether a person needs medically managed alcohol withdrawal first, such as at our alcohol detox retreats near Santa Cruz, or can begin directly in residential treatment. It also helps the team prepare the right staffing and medication orders before you arrive, which matters most in the first 24 to 72 hours.

The count also supports the insurance conversation. Benefits reviews often ask about medical necessity, and a clear, specific history (amount, duration, prior withdrawal) is more useful than a general description. If you want to know what your plan covers before you call, you can verify your insurance online first.

For Families Helping Someone Prepare

Family members often notice the containers before the person drinking does: the recycling bin, the frequency of store runs, the switch from wine to vodka. If you are helping a loved one prepare, you can share what you have observed with the admissions team, but the most accurate count usually comes from the person themselves, ideally with the seven-day list above. Approach the conversation as a practical task (“let’s get the numbers right for the call”) rather than a confrontation.

NIAAA describes alcohol use disorder as a medical condition that can be mild, moderate, or severe, and notes that evidence-based treatment, including behavioral therapies, mutual-support groups, and medications, can help people recover. Its overview, Understanding Alcohol Use Disorder, is a useful plain-language read for families. If you are not sure where to start, SAMHSA’s National Helpline at 1-800-662-4357 is free, confidential, and available 24 hours a day, 365 days a year.

Ready to Talk Through Your Numbers?

You do not need a perfect count to call. Bring what you have, and our admissions team will walk through the rest with you. Reach us at (877) 328-1968. If you are in crisis or having thoughts of harming yourself, call or text 988, or call 911 in an emergency.

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Standard drink figures are approximate and vary with exact container size and alcohol content. Do not stop drinking abruptly if you drink heavily every day; alcohol withdrawal can be dangerous and requires medical supervision. Always consult a qualified healthcare provider about your individual situation.

/by

Buprenorphine and Methadone in Residential Treatment: Staying on Your Medication, the 72-Hour Rule, and What to Tell Admissions

, ,
what happens during the first week of residential addiction treatment - forest path symbolizing early recovery

One of the most common questions on our admissions line comes from someone who is already doing something right: they take buprenorphine or methadone for opioid use disorder, and they want to know whether going into residential treatment means they will be asked to stop. The short answer at most quality programs today is no. The longer answer involves a few federal rules, some logistics that differ between the two medications, and a handful of details you can gather before you call. This guide walks through all of it from the admissions side of the desk.

The Short Answer: Medication and Residential Care Are Not Either-Or

For many years, some residential programs treated medications for opioid use disorder (MOUD) as something a person had to taper off before they could be “really” in recovery. That position no longer reflects mainstream clinical guidance. The Substance Abuse and Mental Health Services Administration (SAMHSA) describes buprenorphine, methadone, and naltrexone as evidence-based treatments for opioid use disorder, and the American Society of Addiction Medicine (ASAM) National Practice Guideline supports continuing them across levels of care rather than stopping them at the door. The National Institute on Drug Abuse (NIDA) likewise describes these medications as effective treatment, not a substitute addiction.

Residential treatment adds what medication alone does not: structure, daily therapy, time away from the people and places tied to use, and a team watching for co-occurring mental health concerns. Medication steadies the body so that work can happen. At Bodhi, our residential treatment program is built around that combination.

Buprenorphine and Methadone Are Handled Differently

Families are often surprised to learn that the two most common opioid use disorder medications follow very different rules in a residential setting.

Buprenorphine for opioid use disorder can be prescribed by any clinician whose standard DEA registration covers Schedule III medications. The separate “X-waiver” that once limited who could prescribe it was eliminated by federal law in the Consolidated Appropriations Act of 2023, and SAMHSA has published guidance confirming the change. In practice, a residential program’s medical provider can usually continue a person’s existing buprenorphine dose, or coordinate with their outside prescriber, without a gap.

Methadone for opioid use disorder is different. Under federal regulations, methadone for addiction treatment can only be dispensed through a certified opioid treatment program (OTP), the clinics many people know as methadone clinics. A residential program cannot simply write a methadone prescription the way a doctor writes one for pain. Continuing methadone during a residential stay depends on coordination with the person’s home clinic or a clinic near the facility, often through what clinics call “guest dosing,” take-home doses where the clinic allows them, or transport to a nearby OTP. This is solvable, but it takes advance work, and it is the single biggest reason a methadone admission takes longer to schedule than a buprenorphine admission.

The 72-Hour Rule, Stated Plainly

Under federal DEA regulation (21 CFR 1306.07(b)), a practitioner who is not part of an opioid treatment program may administer narcotic medication to relieve acute opioid withdrawal for no more than 72 hours (three days) while arrangements are made to refer the person into ongoing treatment. For someone entering residential treatment on methadone, this means a short bridge is possible in some situations, but it is not a substitute for a confirmed dosing plan with an opioid treatment program. If the methadone plan is not settled before admission day, the risk is a gap in medication that can bring on withdrawal, cravings, and early departure from treatment.

That paragraph is the one to share with anyone in the family who is coordinating the admission. Three days is a bridge, not a plan.

What Goes Wrong When Medication Continuity Breaks

From the admissions and clinical side, medication problems in residential care tend to come from a few predictable places:

  • Unknown dose: The person knows they take “the strips” but not the milligram amount, so the medical team has to verify before continuing, which can delay the first dose.
  • Unreachable prescriber: The outside prescriber or clinic cannot be reached on a Friday afternoon, and without verification the team cannot safely confirm the regimen.
  • Missing clinic coordination: A person on methadone arrives without a guest-dosing or transfer arrangement, and the 72-hour window starts running.
  • Undisclosed co-use: Alcohol or benzodiazepine use was not mentioned, which changes the withdrawal picture entirely and the level of medical monitoring required.
  • Tolerance drop at discharge: A person who leaves treatment and returns to opioid use without medication may have lower tolerance than before, which raises overdose risk sharply.

Each of these is preventable with information gathered before admission day.

A Safety Note on Alcohol and Benzodiazepines

Opioid withdrawal is miserable but is rarely life-threatening on its own in otherwise healthy adults. Withdrawal from alcohol and benzodiazepines is different: both can cause seizures and other dangerous complications, and stopping either one requires medical supervision. Many people who use opioids also use one of these, sometimes without thinking of it as relevant. If you or your loved one drinks daily or takes benzodiazepines such as alprazolam, clonazepam, or diazepam, prescribed or not, say so on the first call. It changes the medical plan, and no one will be turned away for being honest about it.

Mixing opioids with alcohol or benzodiazepines also increases the risk of fatal overdose. Keep naloxone on hand, and if someone is unresponsive or breathing slowly, call 911.

What to Gather Before You Call Admissions

This is the part you can do today. Before calling us at (877) 328-1968, write down the following:

  1. Medication name and exact dose. For buprenorphine, include the form (film, tablet, or monthly injection) and the milligrams per day. For methadone, the current daily dose in milligrams.
  2. Time and date of the last dose. And the date of the next scheduled dose or injection.
  3. Prescriber or clinic contact. Name, phone number, and the best hours to reach them. For methadone, the name of the opioid treatment program and the counselor or dosing nurse if you know it.
  4. Pharmacy. Name and phone number. California prescribers can also check the state’s prescription drug monitoring database, known as CURES, but having the pharmacy on hand speeds things up.
  5. Every other substance and medication. Especially alcohol, benzodiazepines, sleep medications, and stimulants, with rough amounts.
  6. Insurance card. Front and back. You can also start with our insurance verification form.

Then ask one specific question on the call: “Will my current dose be continued on day one, and who confirms it with my prescriber or clinic?” A clear answer to that question tells you more about a program’s readiness than any brochure.

What the First Days Usually Look Like

When the information above is in hand, the first days are fairly routine. The medical team verifies the regimen, continues the dose on schedule, and watches for signs that it needs adjusting, since stress and changes in sleep can affect how a person feels on the same dose. Therapy starts alongside medication, not after it. People often tell us that the relief of not having to hide their medication, or argue for it, lets them settle into the work faster.

Some people do decide, with their care team, to change medications or taper over time. That is a clinical decision made deliberately and individually, not a condition of admission. If tapering is ever considered, it should be gradual, monitored, and paired with a clear relapse and overdose prevention plan.

Planning for Discharge Before Admission

The weeks after residential treatment are a high-risk period. Before discharge, the plan should name who will prescribe buprenorphine or which clinic will dose methadone, when the first outpatient appointment is, and whether a naloxone kit is going home with the person. Stepping down to outpatient treatment with medication continuity intact is one of the most protective steps a person can take after a residential stay.

If you or someone you love takes buprenorphine or methadone and is considering residential care in Northern California, call us at (877) 328-1968. We will walk through the medication plan with you before any admission date is set. If you are in crisis, call or text 988, or call 911 in an emergency.

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Medication decisions should be made with a qualified healthcare provider. Do not stop or change any prescribed medication without medical guidance. Alcohol and benzodiazepine withdrawal can be life-threatening and require medical supervision.

/by

GHB and GBL Dependence and Residential Treatment: Round-the-Clock Dosing, Withdrawal Within Hours, and What to Tell Admissions

,
Crop 0 0 1200 628 0 Featuredimage3 — Bodhi Addiction Treatment & Wellness

GHB, and the closely related products GBL and 1,4-butanediol, get less attention than fentanyl or methamphetamine, but for the people who become dependent on them the withdrawal is one of the most time-sensitive situations an admissions team handles. This guide explains, in procedural terms, how residential treatment approaches GHB-type dependence, why timing matters more than almost anything else, and exactly what to have ready when you call admissions.

Why GHB Withdrawal Is Handled as a Medical Priority

GHB (gamma-hydroxybutyrate) is a central nervous system depressant. GBL (gamma-butyrolactone) and 1,4-butanediol are sold as solvents or cleaning products and are converted into GHB inside the body, so clinically they are treated as the same problem. Federally, GHB was placed in Schedule I in March 2000, while the prescription form, sodium oxybate, is a Schedule III medication used for narcolepsy. The legal category matters less to an admissions team than the pharmacology: these substances act quickly and leave the body quickly.

GHB, GBL and 1,4-butanediol withdrawal can begin within roughly one to six hours of the last dose, because the drugs are cleared from the body so fast; people who are physically dependent often dose every one to three hours around the clock, including through the night. Withdrawal can progress from anxiety, tremor and insomnia to agitation, hallucinations, delirium and seizures, so stopping these substances requires medical supervision, and a residential program will ask for the exact dosing interval and the time of the last dose before it agrees on where and how admission happens.

That paragraph is the single most important thing in this article. Like alcohol and benzodiazepine withdrawal, GHB-type withdrawal carries a real risk of seizures and delirium. It should never be attempted alone at home, and “tapering yourself down” without a prescriber is not a safe plan.

What We Actually See on Admissions Calls

From the admissions and intervention side of this work, the pattern on GHB calls is consistent. The person calling is often a partner or friend, not the person using. They describe someone who sets alarms at night to dose, who carries a small bottle or a water bottle with a measured amount in it, and who becomes shaky, sweaty and frightened within a few hours of missing a dose. Families frequently describe it as “anxiety” or “not sleeping” before they connect it to the bottle.

The detail that most often goes unreported is the dosing interval. People will tell us how much they use per day, but not how many hours they can go between doses. For GHB, the interval is the number that tells a clinician how dependent the body is and how quickly withdrawal will start. A person who is dosing every 90 minutes is in a very different medical situation from someone who uses on weekends.

The second inconvenient truth: GHB is not on a standard urine drug panel. A routine test will usually come back negative, and the substance is typically detectable in urine for only about 12 hours. That means the clinical team depends on what you tell them. Honest, specific information is what keeps the admission safe.

What Drives the Risk: Labelled Causes

  • Short half-life: GHB is eliminated within hours, so withdrawal arrives fast and can escalate the same day the last dose was taken.
  • Round-the-clock dosing: Dosing every one to three hours keeps the brain continuously adapted to the drug, which increases the severity of withdrawal when it stops.
  • Hidden product switching: Many people move from GHB to GBL or 1,4-butanediol because they are easier to buy, and the dose equivalence between products is unpredictable.
  • Alcohol and sedative combinations: Mixing GHB with alcohol, benzodiazepines or opioids raises overdose risk and complicates withdrawal planning.
  • No test confirmation: Because standard panels miss GHB, an under-reported history can lead to an under-planned withdrawal.

How the Admissions Process Works for GHB-Type Dependence

When you call, the admissions team is trying to answer one question first: is this person safe to admit directly to residential care, or do they need hospital-level medically managed withdrawal before residential treatment begins? The ASAM Criteria, the framework most programs and insurers use to match people to a level of care, treat withdrawal risk as its own dimension of assessment for exactly this reason.

In practice the steps look like this:

  1. Screening call: substance or substances, amount per dose, interval between doses, time of last dose, any past withdrawal seizures or delirium, and other substances used.
  2. Medical review: a clinician reviews the history and decides whether withdrawal can be managed in a medically monitored setting or whether a hospital detox comes first.
  3. Insurance verification: benefits are checked so the family knows what is covered before travel. You can start that step through our insurance verification page.
  4. Arrival timing: because withdrawal starts within hours, travel is planned so the person is not stranded between their last dose and medical care.
  5. Transition into residential care: once withdrawal is stable, the person moves into the full residential treatment program, where the longer work on dependence, sleep, anxiety and relapse prevention begins.

If you are unsure whether residential care is the right level, a free consultation can walk through the options before anyone commits. You can also call us directly at (877) 328-1968.

What to Do Today: A Checklist for the Admissions Call

Before you call, write down the following on a single sheet of paper or in a phone note. This takes about ten minutes and it is the most useful thing a family can bring to the first conversation.

  • Which product: GHB, GBL, 1,4-butanediol, or more than one. If you do not know, say so.
  • The usual dose and how it is measured (capful, syringe, milliliters).
  • The longest time the person has gone between doses in the past week, and what happened when they did.
  • The exact time of the most recent dose.
  • Any history of seizures, hallucinations, confusion or a hospital visit during withdrawal.
  • Alcohol, benzodiazepines, opioids, stimulants or prescription medications also being taken.
  • Insurance card details and a list of current prescriptions.

Then ask admissions one direct question: “Based on this dosing interval, will withdrawal be managed on site, or do you need a hospital to handle the first phase?” A clear answer to that question tells you the program has thought about GHB specifically.

Safety in the Meantime

Do not stop GHB, GBL or 1,4-butanediol abruptly without medical support, and do not substitute alcohol or someone else’s benzodiazepines to get through withdrawal. Both can cause dangerous sedation, and alcohol and benzodiazepine withdrawal also carry seizure risk that requires medical supervision.

Call 911 or go to an emergency department if someone has a seizure, cannot be woken, is breathing slowly, is severely confused or is seeing or hearing things that are not there. GHB overdose can cause sudden unconsciousness, and the combination with alcohol is especially risky. If there is any chance opioids are involved, give naloxone if it is available while waiting for help.

For help finding care any time of day, the SAMHSA National Helpline is free and confidential at 1-800-662-4357. If someone is in emotional crisis or thinking about suicide, call or text 988.

What Residential Treatment Adds After Withdrawal

Getting through withdrawal is the start, not the treatment. People who have dosed around the clock often have weeks of disrupted sleep, rebound anxiety and strong cravings tied to the nighttime routine. Residential care gives structure to those weeks: individual and group therapy, treatment of co-occurring anxiety, depression or trauma, and a plan for the sleep problems that frequently drove GHB use in the first place. The National Institute on Drug Abuse describes GHB among the depressants with risks of dependence and overdose, and it frames substance use disorders as treatable conditions that respond to sustained care.

Recovery from GHB-type dependence is possible. It goes most smoothly when the first phone call contains accurate, specific information and the program has a clear medical plan for the first 24 to 72 hours.

If you are preparing for that call now, our admissions team is available at (877) 328-1968.

This article is for educational purposes only and is not medical advice. It does not replace an evaluation by a qualified healthcare provider. GHB, GBL and 1,4-butanediol withdrawal can be life-threatening and requires medical supervision. If you or someone you love is in immediate danger, call 911.

/by

Cannabis Use Disorder and Residential Treatment: The Two-Week Withdrawal Window, Hyperemesis, and What to Tell Admissions

,
Two chairs in a living-room-style therapy space — EMDR trauma processing in residential addiction treatment

“It’s just weed” is one of the most common phrases on an admissions call, and it usually comes from someone who has already tried to stop on their own and could not get through the first week. In California, where adult-use cannabis has been legal for people 21 and older since 2016, it can feel strange to ask for residential treatment for something sold in a storefront. Legal status does not change the diagnosis, though, and it does not change what the first two weeks off a daily habit feel like.

This guide covers how cannabis use disorder is assessed, what withdrawal actually involves, why cannabinoid hyperemesis syndrome matters for planning, and the specific details admissions needs from you so the first days of residential treatment are built around your real pattern of use.

Cannabis Withdrawal in Residential Treatment: The Short Answer

Cannabis withdrawal is real and it is usually not medically dangerous on its own, but it is uncomfortable enough to drive relapse. According to the National Institute on Drug Abuse, cannabis withdrawal symptoms such as irritability, poor sleep, low appetite, restlessness, and cravings typically peak within the first week after stopping and can last up to two weeks. There is currently no FDA-approved medication for cannabis use disorder, so residential care for cannabis focuses on managing sleep, appetite, anxiety, and cravings through those first 14 days while therapy addresses why use became daily. The planning changes significantly if alcohol or benzodiazepines are also being used, because withdrawal from those substances can cause seizures and requires medical supervision.

How Cannabis Use Disorder Is Diagnosed

Clinicians use the DSM-5 criteria for cannabis use disorder, the same 11-criterion framework used for other substances. It includes items such as using more than intended, unsuccessful attempts to cut down, cravings, giving up activities, continued use despite problems, tolerance, and withdrawal. Two or three criteria within a 12-month period indicate a mild disorder, four or five moderate, and six or more severe.

Residential care is generally considered when the disorder is moderate to severe and outpatient attempts have not held, when there is a co-occurring mental health condition, or when home is not a place where stopping is realistic. That level-of-care decision follows the ASAM Criteria from the American Society of Addiction Medicine, not the substance alone.

Why the First Week Is Harder Than People Expect

Most people who call us are surprised by how much the first several days hurt. The mechanisms are fairly consistent:

  • Sleep rebound: Many daily users rely on cannabis to fall asleep, and stopping often brings insomnia and vivid, intense dreams for several nights.
  • Appetite loss: Low appetite and nausea are common early, which matters more for someone who has also had vomiting episodes.
  • Irritability and anxiety: Mood is often at its worst in the first days, and this is when people most often talk themselves into leaving.
  • Concentrate tolerance: People using high-potency vape cartridges or dabs throughout the day tend to describe a rougher withdrawal than people smoking flower occasionally, which is why potency and route are asked about at intake.
  • Conditioned cues: When cannabis has been part of every evening, every drive, or every social plan, cravings are tied to routine as much as to chemistry.

None of this is a reason to avoid treatment. It is the reason a structured setting helps: the hardest days happen where staff can adjust sleep routines, nutrition, and support in real time.

Cannabinoid Hyperemesis Syndrome: The Detail That Changes the Plan

Cannabinoid hyperemesis syndrome (CHS) is a pattern of repeated, severe vomiting episodes in some people with long-term, heavy cannabis use. A recognizable sign is relief from hot showers or baths, sometimes taken many times a day. Episodes can lead to dehydration and emergency department visits. The Centers for Disease Control and Prevention and NIDA both describe vomiting syndromes among the health effects of frequent use.

Stopping cannabis is generally the only lasting treatment for CHS, and symptoms can take time to settle after use ends. If you have had vomiting episodes, ER visits for vomiting, or a habit of long hot showers to feel better, tell admissions. It affects hydration monitoring, whether medical clearance is needed before arrival, and how the first days are staffed.

When Medical Supervision Is Required

Cannabis alone rarely requires medical detox. Combined use is a different matter. If you are also drinking daily or taking benzodiazepines such as alprazolam, clonazepam, or lorazepam, whether prescribed or not, withdrawal from those substances carries a risk of seizures and must be medically supervised. Do not stop alcohol or benzodiazepines abruptly on your own before admission. Tell admissions exactly what you take and how much, and let the clinical team decide whether detox comes first.

Heavy cannabis use, especially high-potency products, can also be associated with psychotic symptoms in some people, according to NIDA’s research report on cannabis. Paranoia, hearing things others do not, or a past psychotic episode should be shared up front so a psychiatric assessment can be arranged. If you or someone you love is in crisis right now, call or text 988, or call 911.

What to Tell Admissions: A Checklist You Can Use Today

Before you call, write down answers to these questions. It takes about ten minutes and makes the assessment more accurate:

  1. Product and route: Flower, vape cartridges, dabs or other concentrates, edibles, or a mix.
  2. Frequency and timing: How many times a day, whether you use on waking, and the date and time of last use.
  3. Other substances: Alcohol, benzodiazepines, sleep medications, stimulants, opioids, or nicotine, with amounts. This is the most important item on the list for safety.
  4. Vomiting history: Any repeated vomiting episodes, ER visits, or relief from hot showers.
  5. Mental health history: Anxiety, depression, panic, paranoia, or any past psychotic symptoms, plus current prescriptions.
  6. Previous attempts to stop: How long you lasted and what made you start again. That answer often shapes the treatment plan more than anything else.
  7. Medical cannabis recommendation: If you have one, say so and name the condition it was for, so the team can plan how that condition will be managed.

Our admissions team can walk through these with you by phone at (877) 328-1968.

What to Ask Admissions

  • How is insomnia handled during the first two weeks, and which sleep medications are and are not used?
  • Is a medical evaluation done on arrival if I have had vomiting episodes or combined alcohol or benzodiazepine use?
  • What therapy approaches are used for cannabis use disorder specifically?
  • Will I see a psychiatric provider if anxiety or mood symptoms are part of the picture?
  • What is my insurance likely to cover? You can start that process through our insurance verification page.

A Note From the Admissions Side

The pattern we see most often is not someone in physical danger from cannabis. It is someone who has stopped many times, made it three or four days, and restarted when sleep fell apart or anxiety spiked. Often there is a second substance in the background, usually alcohol, that nobody mentioned on the first call because the conversation was framed around cannabis. Those are the two facts worth bringing to the phone: how far into withdrawal you have gotten before, and everything else you are taking. They shape the plan more than the amount of cannabis does.

If you are weighing residential care for yourself or a family member, call (877) 328-1968 to talk through the level-of-care questions. You can also contact the free, confidential SAMHSA National Helpline at 1-800-662-4357 for referrals at any time.

This article was written by Jonathan Beazley, CADC-CAS, M-RAS, CCMI-i. It is for educational purposes only and is not medical advice, diagnosis, or treatment. Withdrawal from alcohol or benzodiazepines can cause seizures and must be medically supervised. Always consult a qualified healthcare provider about your specific situation. If you are in crisis, call or text 988 or call 911.

/by

Young Adults on a Parent’s Insurance and Residential Treatment: The Age-26 Rule, the Age-18 Privacy Line, and What to Tell Admissions

, ,
A group of people gathered around a table — supporting a loved one during the first weeks of residential rehab

When the person who needs residential treatment is 19, 22 or 25, the phone call to admissions usually comes from a parent. The parent often holds the insurance card, may be paying the deductible, and has watched the last year unfold up close. The young adult, meanwhile, is legally an adult who makes their own medical decisions. Most of the friction we see in admissions for this age group comes from those two facts colliding, not from the clinical picture itself.

This guide walks through the practical side: how coverage on a parent’s plan works, what a parent can and cannot be told once their child is over 18, and what to have ready when you call.

The Short Version: Age 26 for Coverage, Age 18 for Privacy

Under the Affordable Care Act, a young adult can generally stay on a parent’s health plan until age 26, and that plan’s substance use disorder benefits apply to them as a dependent in the same way they apply to the policyholder. Once that young adult turns 18, however, a residential treatment program needs the young adult’s own signed consent before it can share anything about their care with a parent, even when the parent is the policyholder and is paying the bill. Coverage follows the insurance card; information follows the patient’s signature.

Federal confidentiality rules for substance use disorder records, known as 42 CFR Part 2, are stricter than general medical privacy rules. Without a valid written consent, staff generally cannot confirm to a caller that a specific adult is even admitted. Families who learn this on day two often read the silence as the program shutting them out. It is the law working as designed, and it can be addressed before admission rather than after.

Why This Age Group Needs Extra Planning

SAMHSA’s National Survey on Drug Use and Health has consistently found that adults ages 18 to 25 have among the highest rates of substance use disorder of any age group. The National Institute on Drug Abuse also notes that the brain continues developing into the mid-twenties, particularly the regions involved in judgment and impulse control. Those are the clinical reasons this group matters. The logistical reasons are just as real:

  • Split decision-making: The parent controls the insurance and often the money, while the young adult controls consent, so neither can complete admission alone.
  • Thin medical history: Many young adults have no regular primary care doctor, so medication lists, prior diagnoses and past treatment have to be reconstructed at intake.
  • School and work deadlines: A semester withdrawal date or a new job’s probation period creates pressure to delay or shorten care, and that pressure often shows up mid-stay.
  • Underestimated withdrawal risk: Families sometimes assume a young, healthy person can stop anything safely, which is not true for alcohol, benzodiazepines or opioids.

What Happens in the First Week

From the clinical side, the first week for a young adult tends to look different from what parents expect. Many arrive ambivalent, having agreed to come largely because of family pressure. Sleep is often disrupted for several nights. Phone and social media access is usually limited, and for someone in their early twenties that loss can feel larger than the substance itself. It is common for a young adult to call home in the first 72 hours asking to leave. Parents who have talked through that possibility in advance, and agreed together on how they will respond, handle that call far better than parents hearing it cold.

Withdrawal safety does not change with age. Alcohol and benzodiazepine withdrawal can cause seizures and requires medical supervision. Many young adults are using Xanax or other benzodiazepines bought outside a pharmacy, which may be counterfeit and contain different drugs, so an accurate account of what was actually taken matters more than the name on the pill. Opioid withdrawal is rarely life-threatening on its own, but tolerance drops quickly, and returning to use after even a short break carries a serious overdose risk, especially with fentanyl in the supply.

How Insurance on a Parent’s Plan Works

A dependent’s residential treatment is billed under the parent’s policy, so the parent will usually see an Explanation of Benefits. Deductibles and out-of-pocket maximums typically apply at the family level. Prior authorization and ongoing concurrent review generally work the same way they would for the policyholder. Our team can check benefits before anyone commits; start at our insurance verification page or call (877) 328-1968.

Two details catch families off guard. First, California law (Civil Code section 56.107, strengthened by AB 1184) allows a person covered as a dependent to ask their health plan to send communications about sensitive services, which include substance use disorder care, to a different address or by a different method. A young adult may use that right, which means the parent may not receive the paperwork they expect. Second, coverage on a parent’s plan ends at 26. When it ends depends on the plan; many employer plans run through the end of the birthday month, but confirm with the plan. Losing that coverage typically opens a 60-day special enrollment window, through HealthCare.gov or Covered California, so a stay that crosses a 26th birthday needs a coverage plan in place before the birthday arrives.

What to Do Before You Call Admissions

Here are steps a family can take today, before the first call:

  1. Agree on who speaks for whom. If the young adult is willing, they should be on the phone, even briefly. Admissions will need to hear from them directly at some point.
  2. Ask the young adult to sign a consent at intake that names each parent and lists exactly what may be shared: attendance, general progress, discharge date, or the full clinical picture. Narrow consent is still far better than none.
  3. Write down every substance used in the past 30 days, with rough amounts and the date and time of last use. Include pills of uncertain origin.
  4. Gather the insurance card, policyholder date of birth and employer name. If the young adult turns 26 within the next three months, say so on the first call.
  5. List school or work deadlines. A treatment team can often work with a letter for a dean or HR office, but only if they know about the deadline early.

If you want to talk any of this through, reach our admissions team at (877) 328-1968. Calls are confidential.

What We Observe in Practice

Working with families in Northern California, a few patterns come up repeatedly with young adult admissions. The consent conversation goes better when the young adult hears that they control the scope; offering a choice of what to share tends to get a yes, while demanding full access tends to get a refusal. Parents who arrange the 26th-birthday coverage question on day one avoid a mid-stay scramble. And young adults who leave in the first days often return later; the work done on consent, history and insurance is not wasted if that happens.

Residential care for this age group usually includes individual therapy, group therapy with peers, family sessions with consent, and planning for what comes next, including school or work re-entry and step-down care. You can read more about our residential treatment program and how it connects to outpatient treatment after discharge.

If Things Are Urgent Right Now

If your young adult is showing signs of overdose, such as slow or stopped breathing, blue lips or being unresponsive, call 911 and give naloxone if you have it. If they are in emotional crisis or talking about suicide, call or text 988. For free, confidential treatment referral information, the SAMHSA National Helpline is available at 1-800-662-4357, 24 hours a day.

Questions to Ask Admissions

  • What consent form will my child be asked to sign, and can we see it in advance?
  • Who on the clinical team will be the family’s point of contact once consent is in place?
  • How is withdrawal assessed and managed on site, and when would someone be sent to a hospital?
  • How are family sessions scheduled, and are they available remotely?
  • If coverage changes during the stay, how is billing handled?

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Insurance rules and timelines vary by plan; confirm details with your insurer. Never stop alcohol, benzodiazepines or other prescribed medications abruptly without medical supervision.

/by

Ketamine Use and Residential Treatment: No Detox Medication, Bladder Symptoms, Prescribed Ketamine, and What to Tell Admissions

, ,
Crop 0 0 1200 628 0 Featuredimage2 — Bodhi Addiction Treatment & Wellness

Ketamine rarely comes up first on an admissions call. People mention alcohol, pills, or stimulants, and ketamine surfaces ten minutes in, usually described as “not really the problem” or “something my doctor started.” This guide covers what residential treatment actually does when ketamine is part of the picture: how use is assessed, why there is no detox medication for it, what happens to the bladder, how a legitimate ketamine prescription is handled, and exactly what to tell admissions so the first week is planned correctly. If you want to talk it through now, call (877) 328-1968.

The Short Version: How Ketamine Is Classified and Treated

Ketamine is a Schedule III controlled substance under federal law, approved as an anesthetic, and there is no FDA-approved medication for treating ketamine use disorder. Esketamine (Spravato), the FDA-approved nasal spray for treatment-resistant depression, can only be given in a certified healthcare setting, where the patient is monitored for at least two hours after each dose and cannot take the medication home. So when someone has ketamine at home in powder, liquid, or lozenge form, it is either illicit, diverted, or prescribed off-label by a telehealth or clinic prescriber, and residential treatment for problematic ketamine use relies on medical monitoring, symptom management, and behavioral therapy rather than a replacement medication.

How Admissions Decides Whether Ketamine Use Is a Disorder

In the DSM-5, ketamine falls under the phencyclidine-type substances. A use disorder is diagnosed when at least two of the listed criteria occur within a 12-month period: using more than intended, failed attempts to cut down, cravings, giving up activities, continued use despite physical or psychological harm, tolerance, and so on. One difference matters for planning: unlike alcohol or opioids, the criteria list does not include a defined withdrawal syndrome. That does not mean stopping is easy. It means the difficult part is usually psychological rather than a predictable physical withdrawal curve.

A clinician will also use the ASAM Criteria to decide whether residential treatment is the right level of care, looking at medical risk, mental health, readiness, and how safe the home environment is.

Why Ketamine Use Escalates

From the admissions side, these are the patterns that come up again and again. They are clinical observations, not a checklist for self-diagnosis.

  • Fast tolerance: The dissociative effect fades with repeated use, so people take larger amounts or use more often to get the same distance from their thoughts.
  • Dissociation as relief: For someone with depression, anxiety, or trauma, the detached state can feel like the first break in months, which makes it hard to see the use as a problem.
  • The prescription bridge: Some people start with ketamine for depression and begin taking extra doses between sessions or buying more when the supply runs out.
  • Short effect, repeated dosing: The effects wear off relatively quickly, which encourages several doses in a single night.
  • Mixing with depressants: Ketamine is often combined with alcohol or benzodiazepines, which raises the risk of dangerous sedation and slowed breathing.

What the First Week Actually Looks Like

Because there is no standard ketamine detox protocol, the first days in residential care are about watching closely and treating what shows up. People commonly describe low mood, poor or broken sleep, fatigue, irritability, strong cravings, and a flat, foggy feeling sometimes described as “not being back in my body yet.” Families often notice the person sleeping far more than usual early on, then becoming restless and anxious later in the week.

Mood is the part the clinical team watches most closely. When ketamine has been masking depression, that depression can return quickly once use stops. Staff will check in on mood and safety daily and coordinate with psychiatry. If co-occurring depression or anxiety is significant, integrated mental health treatment runs alongside the substance use work rather than after it. The National Institute of Mental Health notes that substance use disorders and mental health conditions frequently occur together and are best treated together.

A safety note that matters more than the ketamine itself: if ketamine has been used alongside daily alcohol or benzodiazepines, withdrawal from those substances can cause seizures and can be life-threatening. That withdrawal requires medical supervision. Do not stop alcohol or benzodiazepines suddenly on your own before admission. Tell admissions exactly how much and how often, so the medical team can plan a supervised taper.

The Bladder Problem Nobody Mentions on the Phone

Regular ketamine use is linked to damage to the bladder and urinary tract, sometimes called ketamine-associated uropathy or ketamine cystitis. Symptoms include needing to urinate very often, urgency, pain when the bladder fills or empties, and blood in the urine. Many people have lived with these symptoms for months and assume they are a recurring urinary tract infection that antibiotics never quite clear.

Stopping ketamine is the most important step, and some people see improvement after they stop, but severe or long-standing damage may need a urologist. A residential medical team can order a urine test, track symptoms, and arrange a referral. Visible blood in the urine, inability to urinate, fever, or severe pain needs prompt medical evaluation, not a wait-and-see approach.

If Your Ketamine Is Prescribed

A legitimate prescription does not disqualify anyone from treatment, and it does not have to be hidden. What admissions needs is the full picture: who prescribes it, the dose, the form, how often it is taken, and whether actual use matches the prescription. If it does match, the medical team will usually contact the prescriber, with your written consent, to decide together whether to pause, continue, or replace it with a different depression treatment during the stay. If use has gone beyond the prescription, say so plainly. It changes the treatment plan, and it is far better for the team to know on day one than to find out on day five.

Do not stop a prescribed depression treatment abruptly before admission without talking to the prescriber first, because mood can drop quickly.

What to Tell Admissions: A Checklist You Can Use Today

Before you or your loved one calls, write these down. It takes about ten minutes and makes the intake assessment much more accurate.

  1. Form and route: powder (snorted), liquid, lozenge, injection, or prescribed nasal or clinic treatment.
  2. Amount and frequency: a typical day or weekend, and the date and time of last use.
  3. Everything else used with it: alcohol, benzodiazepines, opioids, stimulants, cannabis, with amounts for each.
  4. Bladder symptoms: how many times a day you urinate, any pain, and any blood. If you can, keep a simple tally for the next 24 hours.
  5. Mental health history: diagnoses, current medications, and any past suicide attempts or recent thoughts of suicide.
  6. Prescriber details: name, clinic, and phone number if ketamine or esketamine is prescribed.
  7. Insurance card: front and back. You can start a check through our insurance verification page.

Then ask admissions this one question directly: “How will your medical team monitor mood and bladder symptoms in the first week, and who coordinates with my prescriber?” A program that has thought about ketamine will have a specific answer.

For Families: What You Can Do Right Now

Families often see the bathroom trips, the long periods of staring or seeming disconnected, and the mood crashes before the person admits there is a problem. You do not need to prove anything to start a conversation with admissions. Write down what you have observed and when, and call. If the person is unsafe, unresponsive, or talking about suicide, call 911 or the 988 Suicide & Crisis Lifeline by calling or texting 988. For free, confidential treatment referrals at any hour, the SAMHSA National Helpline is available, and the National Institute on Drug Abuse maintains research-based information on substances and treatment.

Getting Started in Northern California

Ketamine use is treatable, and recovery does not depend on a medication that does not exist. It depends on a careful first week, honest information at intake, and treatment that addresses whatever the ketamine was covering up. Our admissions team can walk you through the assessment, insurance, and next steps. Call (877) 328-1968 to speak with someone today.

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Withdrawal from alcohol or benzodiazepines can be dangerous and should only happen under medical supervision. If you or someone you know is in crisis, call or text 988 or call 911.

/by

Meth and Cocaine Use Disorder in Residential Treatment: The 2-of-11 Rule, No FDA-Approved Medication, and What to Tell Admissions

, , ,
meth crash

When a family calls about methamphetamine or cocaine, the first question is almost always some version of “Is there a medication for this, like there is for opioids?” The answer shapes everything else about the admissions process, so it is worth starting there. This guide walks through how stimulant use disorder is diagnosed, what the first week of residential treatment actually looks like, why the treatment plan is built around behavioral care rather than a prescription, and what to have ready when you call admissions.

The Short Answer: Diagnosis Rules and the Medication Gap

Stimulant use disorder, which covers methamphetamine, cocaine and misused prescription stimulants, is diagnosed under the DSM-5 when a person meets at least 2 of 11 criteria within a 12-month period; 2 to 3 criteria is classed as mild, 4 to 5 as moderate and 6 or more as severe. Unlike opioid or alcohol use disorder, there is currently no medication approved by the U.S. Food and Drug Administration specifically to treat stimulant use disorder, so residential treatment for meth or cocaine is built mainly on behavioral therapies such as contingency management and cognitive behavioral therapy, with medical and psychiatric care used to manage sleep, mood and any co-occurring conditions.

The National Institute on Drug Abuse (NIDA) describes behavioral therapies, including contingency management, as the most effective treatments currently available for methamphetamine use disorder, and notes that research into medications is ongoing. That is not a weakness of residential care. It is the reason structure, time and a clinical team matter so much more for stimulants than many families expect.

What the First Week Actually Looks Like

Families often brace for a dramatic physical withdrawal. With stimulants alone, what we usually see instead is a crash. Speaking from years of admissions conversations and placements, the pattern in the first several days is remarkably consistent:

  • Days 1 to 3: long stretches of sleep, sometimes 12 hours or more, heavy appetite, irritability and a flat, exhausted mood. Families sometimes worry that their loved one is “doing nothing.” Sleeping is the work at this stage.
  • Days 4 to 7: energy starts to return unevenly. Low mood, anxiety and intense cravings often come in waves, frequently triggered by boredom, a phone call or a memory.
  • Weeks 2 to 4: sleep begins to normalize for many people, but anhedonia, the sense that nothing feels rewarding, can linger. This is the stretch where people most often want to leave, saying “I feel fine now.”

Timelines vary from person to person, and these are clinical observations rather than fixed rules. The key point is that the most dangerous period for leaving early is usually not day one, but the second and third week, when the crash has lifted and the brain’s reward system has not yet recovered.

Why Stimulant Withdrawal Still Needs Clinical Oversight

Withdrawal from stimulants alone is generally not considered physically life-threatening in the way alcohol withdrawal can be. That does not mean it is safe to go it alone. Three mechanisms drive the clinical risk:

Post-crash depression: mood can drop sharply in the days after heavy use stops, and some people experience suicidal thoughts that need same-day psychiatric assessment.

Stimulant-induced psychosis: paranoia, hallucinations or agitation can persist after use stops, particularly after prolonged methamphetamine use, and require medical evaluation rather than waiting it out.

Hidden co-use: many people who use stimulants also use alcohol, benzodiazepines or opioids to come down or sleep, and withdrawal from alcohol and benzodiazepines carries a real risk of seizures that requires medical supervision.

That third point is the inconvenient truth of stimulant admissions. In our experience, the substance a family calls about is often not the one that determines the level of care. A person described as “only using meth” who also drinks every night to sleep may need medically supervised detox before or at the start of residential treatment. Never stop alcohol or benzodiazepines abruptly without a medical team involved.

If you or a loved one is having thoughts of suicide, call or text 988, the Suicide and Crisis Lifeline, or call 911 in an emergency.

How Treatment Is Structured Without a Medication

Because there is no FDA-approved medication, a strong residential program for stimulant use disorder is defined by what it does with the day. When you compare programs, these are the components to look for:

  • Contingency management: a structured system that provides tangible rewards for verified outcomes such as negative drug tests. SAMHSA has supported wider use of contingency management for stimulant use disorders, and it is one of the best-studied approaches available.
  • Cognitive behavioral therapy: practical work on identifying triggers, planning for high-risk situations and handling cravings without acting on them.
  • Psychiatric evaluation: screening for depression, anxiety, ADHD, bipolar disorder and psychosis, since co-occurring conditions are common and can be mistaken for, or masked by, stimulant effects.
  • Sleep and nutrition support: weight loss, dental problems and badly disrupted sleep are common after long stimulant runs, and recovery goes better when the body is rebuilt alongside the mind.
  • Family involvement: education for relatives about the crash, the “I feel fine” phase and what a realistic aftercare plan looks like.

Medications may still be part of a person’s care, for example to treat co-occurring depression or to support sleep, but those decisions belong to the prescribing clinician and are made case by case. You can learn more about how this level of care works on our residential treatment page.

The Fentanyl Factor

The Centers for Disease Control and Prevention (CDC) has reported that a growing share of overdose deaths involving stimulants also involve opioids, particularly illegally made fentanyl. Some of that is intentional co-use, and some is contamination the person never knew about. For admissions, this means two things: the clinical team will want to know about any possible opioid exposure, and the discharge plan should include naloxone and overdose education, because tolerance drops during treatment.

What to Do Before You Call Admissions

The most useful thing you can do today is write down the following before the call, even if the answers are rough estimates. Admissions teams use this to decide whether a person needs detox first, residential care directly, or a different level of care entirely.

  1. Last use: the date and approximate time stimulants were last used.
  2. Pattern: how often, how much and by what route (smoked, snorted, injected), and how long the current run has lasted.
  3. Everything else: every other substance in the past 30 days, especially alcohol, sleeping pills, benzodiazepines such as Xanax or Klonopin, and any opioids.
  4. Sleep: roughly how many hours the person has slept in the last 72 hours.
  5. Mental health: any paranoia, hallucinations, or talk of self-harm or suicide, past or present.
  6. Prescriptions and insurance: a current medication list and an insurance card. You can start the benefits check now through our insurance verification page.

Then ask the program three direct questions: “Do you use contingency management, and how?”, “How do you handle the second and third week, when people want to leave?” and “What does your aftercare plan include for stimulant use?” A program that answers these clearly has thought about stimulant recovery specifically, not just addiction in general.

To talk through a specific situation, call (877) 328-1968.

After Residential: Planning the Step-Down

Cravings for stimulants can resurface weeks or months after the crash has passed, often in response to people, places or even payday. That is why the step-down plan matters as much as the residential stay. Most people benefit from moving into a structured outpatient program rather than going straight home without support, with continued therapy, peer support and, where available, ongoing contingency management.

Recovery from stimulant use disorder is possible, and many people do recover with time and the right structure. If you are trying to figure out the right level of care for yourself or someone you love, our team can walk through the options and the insurance questions with you. Call (877) 328-1968 to speak with someone today.

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Withdrawal from alcohol or benzodiazepines can cause seizures and must be medically supervised. If you are experiencing a medical emergency, call 911. If you are in crisis or having thoughts of suicide, call or text 988.

/by